1. Home
  2. THAR vs MXC Comparison

THAR vs MXC Comparison

Compare THAR & MXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THAR
  • MXC
  • Stock Information
  • Founded
  • THAR 2017
  • MXC 1972
  • Country
  • THAR United States
  • MXC United States
  • Employees
  • THAR N/A
  • MXC N/A
  • Industry
  • THAR Biotechnology: Pharmaceutical Preparations
  • MXC Oil & Gas Production
  • Sector
  • THAR Health Care
  • MXC Energy
  • Exchange
  • THAR Nasdaq
  • MXC Nasdaq
  • Market Cap
  • THAR 22.8M
  • MXC 18.4M
  • IPO Year
  • THAR 2022
  • MXC N/A
  • Fundamental
  • Price
  • THAR $3.31
  • MXC $9.49
  • Analyst Decision
  • THAR Strong Buy
  • MXC
  • Analyst Count
  • THAR 1
  • MXC 0
  • Target Price
  • THAR $17.00
  • MXC N/A
  • AVG Volume (30 Days)
  • THAR 2.6M
  • MXC 4.2K
  • Earning Date
  • THAR 11-07-2025
  • MXC 11-07-2025
  • Dividend Yield
  • THAR N/A
  • MXC 1.05%
  • EPS Growth
  • THAR N/A
  • MXC 44.21
  • EPS
  • THAR N/A
  • MXC 0.79
  • Revenue
  • THAR N/A
  • MXC $7,444,407.00
  • Revenue This Year
  • THAR N/A
  • MXC N/A
  • Revenue Next Year
  • THAR N/A
  • MXC N/A
  • P/E Ratio
  • THAR N/A
  • MXC $11.98
  • Revenue Growth
  • THAR N/A
  • MXC 13.06
  • 52 Week Low
  • THAR $0.95
  • MXC $5.89
  • 52 Week High
  • THAR $9.08
  • MXC $16.00
  • Technical
  • Relative Strength Index (RSI)
  • THAR 56.35
  • MXC 55.13
  • Support Level
  • THAR $2.85
  • MXC $8.90
  • Resistance Level
  • THAR $6.89
  • MXC $9.80
  • Average True Range (ATR)
  • THAR 0.49
  • MXC 0.53
  • MACD
  • THAR 0.04
  • MXC -0.01
  • Stochastic Oscillator
  • THAR 14.85
  • MXC 75.97

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

About MXC Mexco Energy Corporation

Mexco Energy Corporation is an independent oil and gas company. It is engaged in the acquisition, exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.

Share on Social Networks: